PubRank

Haichang Wang

Author PubWeight™ 54.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev 2007 1.65
2 Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med 2008 1.60
3 Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury. J Mol Cell Cardiol 2010 1.54
4 Downregulation of adiponectin induced by tumor necrosis factor α is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury. Crit Care Med 2011 1.50
5 Pulsed magnetic field induces angiogenesis and improves cardiac function of surgically induced infarcted myocardium in Sprague-Dawley rats. Cardiology 2010 1.49
6 Soluble CD40 ligand promotes macrophage foam cell formation in the etiology of atherosclerosis. Cardiology 2015 1.41
7 Can insulin resistance be reversed by insulin therapy? Med Hypotheses 2008 1.41
8 Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur Heart J 2009 1.34
9 Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism. Diabetes 2013 1.28
10 Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One 2012 1.27
11 Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways. Basic Res Cardiol 2013 1.12
12 Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy. Cardiovasc Diabetol 2011 1.11
13 Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function. BMC Med 2012 1.11
14 In vivo imaging and evaluation of different biomatrices for improvement of stem cell survival. J Tissue Eng Regen Med 2008 1.07
15 Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling. Stem Cell Res Ther 2014 1.04
16 TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. Basic Res Cardiol 2014 1.01
17 Coronary vein angioplasty to facilitate implantation of left ventricular lead. Europace 2010 1.01
18 A PKC-beta inhibitor treatment reverses cardiac microvascular barrier dysfunction in diabetic rats. Microvasc Res 2010 0.99
19 Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes. Mol Cell Biochem 2011 0.99
20 Angiotensin II promotes NO production, inhibits apoptosis and enhances adhesion potential of bone marrow-derived endothelial progenitor cells. Cell Res 2008 0.99
21 Toll-like receptor 4 signaling in dysfunction of cardiac microvascular endothelial cells under hypoxia/reoxygenation. Inflamm Res 2010 0.98
22 Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart. Basic Res Cardiol 2013 0.97
23 AMPK-regulated and Akt-dependent enhancement of glucose uptake is essential in ischemic preconditioning-alleviated reperfusion injury. PLoS One 2013 0.97
24 A PKC-beta inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats. Apoptosis 2010 0.96
25 Notch3/Akt signaling contributes to OSM-induced protection against cardiac ischemia/reperfusion injury. Apoptosis 2015 0.93
26 Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction. Basic Res Cardiol 2014 0.92
27 Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells. Antioxid Redox Signal 2011 0.92
28 Effects of ghrelin on homocysteine-induced dysfunction and inflammatory response in rat cardiac microvascular endothelial cells. Cell Biol Int 2012 0.89
29 Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. Atherosclerosis 2009 0.88
30 High glucose sensitizes adult cardiomyocytes to ischaemia/reperfusion injury through nitrative thioredoxin inactivation. Cardiovasc Res 2009 0.86
31 Moderate dose insulin promotes function of endothelial progenitor cells. Cell Biol Int 2011 0.85
32 Insulin inhibits leukocyte-endothelium adherence via an Akt-NO-dependent mechanism in myocardial ischemia/reperfusion. J Mol Cell Cardiol 2009 0.85
33 FTY720 protects cardiac microvessels of diabetes: a critical role of S1P1/3 in diabetic heart disease. PLoS One 2012 0.84
34 Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways. Clin Exp Pharmacol Physiol 2009 0.84
35 Effect of autologous bone marrow mononuclear cells transplantation in diabetic patients with ST-segment elevation myocardial infarction. Int J Cardiol 2012 0.83
36 Changing strategies of the retrograde approach for chronic total occlusion during the past 7 years. Catheter Cardiovasc Interv 2012 0.83
37 NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury. Basic Res Cardiol 2013 0.83
38 Effects and mechanisms of ghrelin on cardiac microvascular endothelial cells in rats. Cell Biol Int 2011 0.81
39 Variation of NDRG2 and c-Myc expression in rat heart during the acute stage of ischemia/reperfusion injury. Histochem Cell Biol 2010 0.81
40 Dynamic alteration of adiponectin/adiponectin receptor expression and its impact on myocardial ischemia/reperfusion in type 1 diabetic mice. Am J Physiol Endocrinol Metab 2011 0.81
41 A conserved TGFβ1/HuR feedback circuit regulates the fibrogenic response in fibroblasts. Cell Signal 2012 0.80
42 Adrenomedullin in Vascular Endothelial Injury and Combination Therapy: Time for a New Paradigm. Curr Vasc Pharmacol 2015 0.80
43 Association between serum levels of soluble CD40/CD40 ligand and organ damage in hypertensive patients. Clin Exp Pharmacol Physiol 2010 0.80
44 PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury. J Nucl Med 2012 0.79
45 The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury. Am J Physiol Endocrinol Metab 2012 0.78
46 Nine-month angiographic and 2-year clinical follow-up of the NOYA biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the NOYA I trial. EuroIntervention 2012 0.78
47 Diagnostic performance of instantaneous wave-free ratio for the evaluation of coronary stenosis severity confirmed by fractional flow reserve: A PRISMA-compliant meta-analysis of randomized studies. Medicine (Baltimore) 2016 0.78
48 Apelin protects sarcoplasmic reticulum function and cardiac performance in ischaemia-reperfusion by attenuating oxidation of sarcoplasmic reticulum Ca2+-ATPase and ryanodine receptor. Cardiovasc Res 2013 0.77
49 Reduced cardiotropic response to insulin in spontaneously hypertensive rats: role of peroxisome proliferator-activated receptor-gamma-initiated signaling. J Hypertens 2008 0.77
50 The possible role of ribosomal protein S6 kinase 4 in the senescence of endothelial progenitor cells in diabetes mellitus. Cardiovasc Diabetol 2012 0.77
51 Pulsed magnetic field accelerate proliferation and migration of cardiac microvascular endothelial cells. Bioelectromagnetics 2014 0.77
52 PLATINUM China: a prospective, randomized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesions. Catheter Cardiovasc Interv 2015 0.76
53 Low strength static magnetic field inhibits the proliferation, migration, and adhesion of human vascular smooth muscle cells in a restenosis model through mediating integrins β1-FAK, Ca2+ signaling pathway. Ann Biomed Eng 2012 0.76
54 Involvement of activated astrocyte and microglia of locus coeruleus in cardiac pain processing after acute cardiac injury. Neurol Res 2009 0.76
55 Caveolin-1 restoration by cholesterol enhances the inhibitory effect of simvastatin on arginine vasopressin-induced cardiac fibroblasts proliferation. Mol Cell Biochem 2009 0.76
56 Multimodality imaging evaluation of functional and clinical benefits of percutaneous coronary intervention in patients with chronic total occlusion lesion. Theranostics 2012 0.76
57 Metabolic syndrome and blood pressure response to sodium. Lancet 2009 0.75
58 A Randomized Comparison of Biodegradable Polymer- and Permanent Polymer-coated Platinum Chromium Everolimus-ElutingCoronary Stents in China: The EVOLVE China Study. EuroIntervention 2017 0.75
59 Acute insulin resistance mediated by advanced glycation endproducts in severely burned rats. Crit Care Med 2014 0.75
60 Early percutaneous intervention improves survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock. Kardiol Pol 2008 0.75
61 Nitric oxide opens second window of protection in ischemic preconditioning via induction of heat-shock protein 72. Chin Med J (Engl) 2003 0.75
62 Exposure of aortic vascular smooth muscle cells to low-frequency electromagnetic field inhibits osteopontin expression and matrix metalloproteinase activity. Int Heart J 2008 0.75
63 Simvastatin promotes cardiac microvascular endothelial cells proliferation, migration and survival by phosphorylation of p70 S6K and FoxO3a. Cell Biol Int 2014 0.75
64 The key features of percutaneous coronary intervention with chronic total obstruction lesion of right coronary artery. Ther Adv Cardiovasc Dis 2014 0.75
65 Generation and identification of natural monoclonal antibodies against low-density lipoprotein. Hybridoma (Larchmt) 2008 0.75
66 S1P1 and S1P3 are potential markers of cardiac microangiopathy in diabetes. Med Hypotheses 2012 0.75
67 Efficacy and Safety of a Biodegradable Polymer Cobalt-Chromium Sirolimus-Eluting Stent (EXCEL2) in Treating De Novo Coronary Artery Disease: A Pooled Analysis of the CREDIT II and CREDIT III Trials. DOI: 10.1002/ccd.26887. Catheter Cardiovasc Interv 2017 0.75
68 Diagnosis of aortic-right ventricular tunnel by dual-source computed tomography. Eur J Cardiothorac Surg 2010 0.75